Wouldnt it be useful to compare Admedus to LeMaitre Vascular Corporation (NASDAQ:LMAT)? They're the mob that WP said had 50 sales reps flogging off patches (incidentally, LeMaiture in their recent CC also blamed hurricanes for a slow down in sales in the previous quarter).
LeMaitre Vascular has a market cap of around $600 million, with a PE of 40.
Applying that PE to Admedus for the projected $20 million in earnings in 2020, that would give Admedus a market cap of about $763 million (a Disallowed in 2 years time). I think my maths is right.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.18 |
Change
0.380(7.92%) |
Mkt cap ! $80.31M | |||
| Open | High | Low | Value | Volume |
| $4.85 | $5.18 | $4.85 | $39.09K | 7.832K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1200 | $4.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.18 | 2066 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| AVR (ASX) Chart |